Integrated Openings Solutions has partnered with Frontenac
Integrated Openings Solutions (IOS) has partnered with Frontenac. This partnership will enable IOS to accelerate expansion into new markets, broaden its product and service offering and continue to pursue strategic combinations with visionary founders of extraordinary businesses.
Founded by management in 2018, IOS is a value-added specialty distributor and service provider offering comprehensive commercial door, opening and access control solutions through a differentiated business model focused on being a one-stop-shop provider across the full lifecycle of an end user’s needs. IOS is headquartered in Olathe, Kansas, with additional locations in the St. Louis, Missouri, Huntsville, Alabama, and Tampa, Naples, and Fort Lauderdale, Florida, and has established itself as a super-regional market leader serving a diverse range of resilient end markets.
Frontenac is a Chicago-based private equity firm focused on investing in lower middle market companies across the consumer, industrial and services industries. Frontenac works in partnership with established operating leaders to build market-leading companies through transformational acquisitions and operational excellence.
Oaklins TM Capital in the US served as the exclusive financial advisor to Integrated Openings Solutions in connection with its partnership with Frontenac.
Joe Lopez
CEO, Integrated Openings Solutions
Contáctese con el equipo de la transacción
Allan C. Cruickshanks
Oaklins TM Capital
James S. Grien
Oaklins TM Capital
Jarrad Zalkin
Oaklins TM Capital
Tabb Neblett
Oaklins TM Capital
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más